This action might not be possible to undo. Are you sure you want to continue?
Working for a healthier world
PRESENTED BY : SEM II 2012-2014
Afzal housaain – PH 1202 Akhil Vyas - PH 1203 Akshay A Nahar – PH 1204 Anudeep - PH 1208 Arvind Maurya - PH 1209 Ashok Kondhare - PH 1210
Welcome to Pfizer
We are the world’s leading healthcare company with:
A 155-year history originating in Brooklyn, NY A market capitalization ranked 4th worldwide Over $45 billion in annual sales in over 150 countries 122,000 colleagues worldwide The largest R&D budget in the world at nearly $8 billion
We will be recognized for meeting the diverse medical needs of patients in Emerging Markets around the world in an innovative, socially responsible and commercially viable manner.
Pfizer world headquarters in New York , USA
4 billion) (2011) (top position) Pfizer is named after German-American cousins Charles Pfizer and Charles Erhart (originally from Ludwigsburg. from a building at the Williamsburg. Inc. United States. Charles Pfizer and Company. is an American multinational pharmaceutical corporation headquartered in New York City . Germany) who launched a fine chemicals business. Brooklyn in 1849. and with its research headquarters in Groton .HISTORY Pfizer. 5 6-Mar-13 . It is the world's largest pharmaceutical company by revenues. ($ 67. Connecticut.
and the company began a search for an alternative supply. World War I caused a shortage of calcium citrate that Pfizer imported from Italy for the manufacture of citric acid. they produced an antiparasitic called santonin.HISTORY There. This was an immediate success. although it was the production of citric acid that really kick-started Pfizer's growth in the 1880. Pfizer chemists learned of a fungus that ferments sugar to citric acid and were able to commercialize production of citric acid from this source in 1919. These skills were applied to the mass production of penicillin during World War II. 6 6-Mar-13 .
Viagra). Puerto Rico. Lipitor. Zithromax. Panama.Diflucan. Mexico.) During the 1980s and 1990s Pfizer underwent a period of growth sustained by the discovery and marketing of multiple successful drugs (Zoloft. Canada. Aricept. 7 6-Mar-13 . Turkey and the United Kingdom. Cuba.HISTORY By the 1950s. Norvasc. Brazil. Pfizer was established in (Belgium. Iran.
ACQUISITIONS COMPANY NAME YEAR OF ACQUISITION WARNER–LAMBERT PHARMACIA 2000 2002 2009 2010 8 6-Mar-13 WYETH KING PHARMACEUTICALS .
89B Industry 1.49M 0.07 2.68 2.75B 1.77B 2.68 0.63 3.05 3.22B MRK 127.000 -0.67K 0.28B Qtrly Rev Growth (yoy): Revenue (ttm): Gross Margin (ttm): EBITDA (ttm): Operating Margin (ttm): Net Income (ttm): EPS (ttm): P/E (ttm): PEG (5 yr expected): P/S (ttm): 0.06 4.55 18.80 26.42B 0.49B SNY 126.93B 123.69B 0.73 6-Mar-13 .31 9.03 0.93 16.66 17.64B 3.719 0.82B NVS 154.56 2.28 20.58B 113.PFE Market Cap: Employees: 190.69 9 0.08 2.06 0.07 57.21 8.25 7.23 6.26 5.12 N/A 0.800 -0.76B 2.71 18.686 -0.55 2.41B 86.68 16.20 19.16 62.54 130.42 2.11 0.47B 98.37B 1.56 17.01 46.77B 0.78B 0.04 47.
10 6-Mar-13 .
M &A Mergers and acquisitions (abbreviated M&A) is an aspect of corporate strategy. selling. dividing and combining of different companies and similar entities that can help an enterprise grow rapidly in its sector or location of origin. without creating a subsidiary. or a new field or new location. 11 6-Mar-13 . other child entity or using a joint venture. corporate finance and management dealing with the buying.
The Pharmaceuticals business consists of manufacturing of drugs and formulations. Pharmaceuticals. and also includes rendering of marketing services. trading of formulations.SEGMENTS Pfizer Limited operates in three segments: 1. Animal Health and 3. Services. 2. 12 6-Mar-13 .
SEGMENTS The Animal Health business has a presence primarily in the animal health and poultry market segments and also includes rendering of marketing services. 13 6-Mar-13 . Services segment consist of clinical development operations primarily include conducting clinical trials. product development and undertaking data management for drug development.
2006. 14 6-Mar-13 .2B in 2005 sales). Animal Health ($2. Consumer Healthcare ($3. On June 26.6 billion.28B in 2005 sales). Visine. finance. and HR.87B in 2005 sales). Nicorette. Pfizer announced that it would sell its Consumer Healthcare unit. Sudafed and Neosporin) to Johnson & Johnson for $16. (manufacturer of Listerine.DIVISIONS Pfizer has four divisions: Human Health ($44. and Corporate Groups (which includes legal.
SEGMENTS 15 6-Mar-13 .
16 6-Mar-13 16 .Central Nervous System Ophthalmology Cardiovascular Respiratory Infectious Disease/HIV Diabetes Endocrinology Oncology Pain/Inflammation Urogenital/Gyn.
In 2007. the largest R&D investment in the pharmaceutical industry.Global R &D of PFIZER Pfizer Global Research and Development is Pfizer's research and development division. 17 6-Mar-13 . Pfizer's human research and development operations are headquartered in New London.1 billion in research and development. and its animal health research and development operations are headquartered in Kalamazoo. Michigan. Pfizer invested $8. CT.
18 6-Mar-13 .
including depression. and osteoporosis. Pfizer scientists have produced innovative breakthroughs in a wide range of research areas. 19 6-Mar-13 . including cancer. HIV infection. hypertension. high cholesterol. erectile dysfunction.PURSUING INNOVATION The pursuit of innovation is basic to Pfizer's culture. And today pfizer taking on some of the world's most difficult diseases. bacterial infections and systemic fungal infections. arthritis.
Martin Mackay Dr.. David Shedlarz Mr. Ian C. Kindler Mr. Freda C. Jeffrey B.CORPORATE MANAGEMENT Mr. Read Dr. FAPA 20 6-Mar-13 . Lewis-Hall M.D.
Mr. Shah was first appointed on the Board on November 9. R. 2012) 21 6-Mar-13 .A. 1996. Pradip P. 1999. Aijaz Tobaccowalla – Managing Director (from August 16. 2012) Mr. Handa was appointed to the Board on December 16.BOARD OF DIRECTORS Mr. Shah – Chairman. Shah – Director Mr. K. Mr. Kewal Handa . 1965. Shah was appointed to the Board on December 7.A. Mr. Pradip P.Managing Director (Upto August 15. Mr. R.
Pfizer has won several awards including that for the multinational pharmaceutical company of the year and the most respected MNC . 22 6-Mar-13 . The company was awarded the FICCI SEDF (Socio Economic Development Foundation) Certificate of Commendation for its social responsibility efforts.96 million (March 2012). Pfizer has made clinical research investments of US$ 1.18 million (March 2012) in India . One of the highest spenders in pharmaceutical R&D globally.PFIZER IN INDIA Pfizer Limited (India) has a turnover of US$ 184.
23 6-Mar-13 . Becosules has won the Most Trusted Brand Award.Corex (Cough Formulation) and Becosules (Multivitamin) -. Two of Pfizer India's brands -. Pfizer has won the Golden Peacock Innovative Product for Magnex (Sulperazon).continue to rank among the Top 15 pharmaceutical drug brands.ABOUT PRODUCTS Six Pfizer brands feature among the Top 100 pharmaceutical brands in India .
The names shown are all registered trademarks of Pfizer. which includes five inherited Inc. Chap Stick Xanax (alprazolam) 2 mg tri-score tablets Bottles of the antidepressant Zoloft 24 6-Mar-13 .PRODUCTS The following is a list of key prescription pharmaceutical products. Pfizer had the greatest number of blockbuster products in 2009 with 14.
25 6-Mar-13 .
Caduet (amlodipine) and (atorvastatin) for cholesterol and hypertension. Diflucan (fluconazole) for antifungal drug Eryc (erythromycin) an antibiotic Viagra (sildenafil) for erectile dysfunction 26 6-Mar-13 . Advil (ibuprofen) Alesse (levonorgestrel/ethinyl estradiol) an oral contraceptive. Aricept (donepezil) for Alzheimer's disease Bextra (Valdecoxib) for arthritis.HUMAN HEALTH Accupril (quinapril) for hypertension treatment.
Viagra • Treats erectile dysfunction (ED) • Cannot exceed the maximum dose of 25mg in 48 hours Benadryl • Treats allergy symptoms • Treating adult allergic reaction 25-50 mg every 4-6 hours Cefazolin • To reduce the development of drug.resistant bacteria • Moderate to sever infection 500 mg.1 gram every 6-8 hours 27 6-Mar-13 .
The particles are accelerated by helium gas in a hand-held device and propelled into the skin. This needlefree delivery is ideal for the delivery of DNA vaccines. PowderMed was acquired by Pfizer in 2006 and the PMED technology is being used in Pfizer vaccine programs. 28 6-Mar-13 .PMED TECHNOLOGY Powder Med developed the Particle Mediated Epidermal Delivery (PMED) technology. PMED delivers DNA vaccines into the skin without needles in a dry powder formulation of gold particles.
29 6-Mar-13 .
30 6-Mar-13 .
31 6-Mar-13 .
MOST VALUED BY OUR PEERS AND INDUSTRY “One of the Top 50 Companies in America” “One of the World’s Best Companies for Leaders” “One of the Top 50 Diversity Employers ” “100 Best Companies to Work For in America” “America’s Most Admired Pharmaceutical Company” “#2 in Training and Developing Employees” “One of top 25 employers for MBAs” 32 6-Mar-13 32 .
CONTOVERSIAL Brigham Young University (Celebrex Royalty) Lawsuit over GMO virus Blue Cross Blue Shield lawsuit Off label promotional practices of GABAPENTIN 33 6-Mar-13 .
Fierce Pharma reported that "According to the suit. but sent doctors on Caribbean junkets and paid them $2.CONTROVERSIAL Off label promotional practices In 1993. migraine. and other unapproved uses. Warner–Lambert admitted to charges that it violated FDA regulations by promoting the drug for pain. the U. to promote gabapentin.000 honoraria in return for their 6-Mar-13 listening to lectures about Bextra. psychiatric conditions. sponsored articles about the drug for the medical literature. 34 . Warner–Lambert. Food and Drug Administration (FDA) approved gabapentin (Neurontin. Pfizer) only for treatment of seizures. the drugmaker not only handed out those "misleading" materials on off-label uses. and paid $430 million to resolve criminal and civil health care liability charges Blue Cross Blue Shield lawsuit Health insurance company Blue Cross Blue Shield (BCBS) filed a lawsuit against Pfizer for reportedly illegally marketing their drugs Bextra.S. BCBS is reporting that Pfizer used "kickbacks" and wrongly persuaded doctors to prescribe the drugs. Geodon and Lyrica. and alleged suppression of unfavourable study results. used activities continuing medical education and research.
SWOT ANALYSIS STRENGTH : Strong sales and marketing infrastructure. Strong R & D department. 35 6-Mar-13 . Marketing strength in major geographical & therapeutic areas. R &D innovation in broad therapeutic coverage.
SWOT ANALYSIS WEAKNESS : Very limited penetration in biologics market. providing pfizer with strong product therefore revenue growth. Discontinuation of products in latter stage of development. Strengths. OPPORTUNITIES : Biological market expansion. 36 6-Mar-13 .
An increase in the no.SWOT ANALYSIS THREATS : Considerable exposure to generic competition. due to lose patent exclusively in 2011. 37 6-Mar-13 . of safety issues surrounding Viagra. focal point of which is Lipitor.
the steady progress of the late-stage pipeline(with 22 projects in phase III and 11 under registration) will be a primary source of confidence for the company. The approval ofXalkori for lung cancer.Pfizer updates The company’s new marketing strategy. Moving ahead. compensated for the losses caused by Lipitor’s patent expiry. financial and R&D restructuring efforts. 38 6-Mar-13 . Inlyta and pneumococcal vaccine Prevnar 13 have proved to be a real lifeline for Pfizer. coupled with focused organisational.
Pfizer updates The key strategy of the group is now to advance experimental drugs towards approval: these include Bosutinib. Pfizer’s huge research budget has been cut by 12%. experimental clot-preventing drug Eliquis and its many pipeline drugs to make up for the inevitable decline in Lipitor revenue. 39 6-Mar-13 . With a view to reducing costs. In 2012. Tofacitinib. Pfizer will focus on small to mid-sized deals and effective research partnerships to strengthen its portfolio in all therapeutic segments.
40 6-Mar-13 .